Selectivity and potency of cyclin-dependent kinase inhibitors
Open Access
- 1 March 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 8 (1), E204-E221
- https://doi.org/10.1208/aapsj080125
Abstract
Members of the cyclin-dependent kinase (CDK) family play key roles in various cellular processes. There are 11 members of the CDK family known till now. CDKs are activated by forming noncovalent complexes with cyclins such as A-, B-, C-, D- (D1, D2, and D3), and E-type cyclins. Each isozyme of this family is responsible for particular aspects (cell signaling, transcription, etc) of the cell cycle, and some of the CDK isozymes are specific to certain kinds of tissues. Aberrant expression and overexpression of these kinases are evidenced in many disease conditions. Inhibition of isozymes of CDKs specifically can yield beneficiary treatment modalities with minimum side effects. More than 80 3-dimensional structures of CDK2, CDK5, and CDK6 complexed with inhibitors have been published. This review provides an understanding of the structural aspects of CDK isozymes and binding modes of various known CDK inhibitors so that these kinases can be better targeted for drug discovery and design. The amino acid residues that constitute the cyclin binding region, the substrate binding region, and the area around the adenosine triphosphate (ATP) binding site have been compared for CDK isozymes. Those amino acids at the ATP binding site that could be used to improve the potency and subtype specificity have been described.Keywords
This publication has 133 references indexed in Scilit:
- Insights into Cyclin Groove Recognition: Complex Crystal Structures and Inhibitor Design through Ligand ExchangeStructure, 2003
- Discovery of a Novel Family of CDK Inhibitors with the Program LIDAEUS: Structural Basis for Ligand-Induced Disordering of the Activation LoopStructure, 2003
- Specificity Determinants of Recruitment Peptides Bound to Phospho-CDK2/Cyclin A,Biochemistry, 2002
- The Hallmarks of CancerCell, 2000
- Tumor suppressor INK4: Refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR dataProtein Science, 2000
- Tumor suppressor INK4: comparisons of conformational properties between p16INK4A and p18INK4CJournal of Molecular Biology, 1999
- Characterization of Novel Inhibitors of Cyclin-Dependent KinasesBiochemical and Biophysical Research Communications, 1999
- Tumor Suppressor INK4: Determination of the Solution Structure of p18INK4C and Demonstration of the Functional Significance of Loops in p18INK4C and p16INK4A ,Biochemistry, 1999
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994